Ketamine Recruiting Phase 2 Trials for Borderline Personality Disorder (BPD) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03395314Ketamine in Borderline Personality Disorder